Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2025-12-29 00:00:00 ET · period of report 2025-12-24 · accession 0001193125-25-335538 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-29 | 2025-12-24 | CORT | BELANOFF JOSEPH K | CEO, Dir | F - Tax | $83.59 | -306.8K | 243.2K | -56% | -$25.65M |
| D | 2025-12-29 | 2025-12-24 | CORT | BELANOFF JOSEPH K | CEO, Dir | G - Gift | $0.00 | -243.2K | 0 | -100% | $0 |
| DI | 2025-12-29 | 2025-12-24 | CORT | BELANOFF JOSEPH K | CEO, Dir | J - Other | $0.00 | +243.2K | 2.94M | +9% | $0 |
| D | 2025-12-29 | 2025-12-24 | CORT | BELANOFF JOSEPH K | CEO, Dir | M - OptEx | $3.88 | +550.0K | 550.0K | New | +$2.13M |
| D | 2025-12-29 | 2025-12-24 | CORT | BELANOFF JOSEPH K | CEO, Dir | M - OptEx | $0.00 | -550.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-24 | F | D | 306,846 | $83.59 | 243,154 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-24 | G | D | 243,154 | $0.00 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-24 | J | A | 243,154 | $0.00 | 2,944,524 | I | — | — | |
| 4 | Common | Common Stock | 2025-12-24 | M | A | 550,000 | $3.88 | 550,000 | D Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 | — | — | (F3) Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. |
| 5 | Derivative | Stock option (right to buy) | 2025-12-24 | M | D | 550,000 | $0.00 | 0 | D | $3.88 · — to 2026-02-26 | 550,000 Common Stock | (F4) Fully exercisable. |